Historical record - last NADAC effective date: 3/22/2023
Product Information
FLUOXETINE HCL 40 MG CAPSULE is a generic product labeled by Vensun Pharmaceuticals, Inc., priced at $0.0736 per EA under NDC 42543072705. Its NADAC has been published 383 times since Dec 2, 2015.
FDA first approved this application on Mar 16, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Vensun Pharmaceuticals, Inc.NDC
42543072705
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
3/22/2023
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204597FDA Approved
3/16/2015
TE Code
AB1
On Market Since
3/16/2015
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 40 MG CAPSULE has been published 383 times since Dec 2, 2015, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.1995 (May 11, 2016) |
| All-time low | $0.0653 (Jan 18, 2023) |
| Median price | $0.0926 |
| Average price | $0.1066 |
| Largest weekly change | -24.3% (Aug 21, 2019) |
| Weeks tracked | 383 |
| Tracking since | Dec 2, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-1.0%
All
-52.9%
Last surveyed Mar 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 40 MG CAPSULE, manufactured by Vensun Pharmaceuticals, Inc., is $0.0736 per EA (NDC 42543072705), effective Mar 29, 2023.
How has the price of FLUOXETINE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has declined 52.9%. It has been tracked across 383 weekly CMS publications since Dec 2, 2015.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 40 MG CAPSULE?
Since Dec 2, 2015, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has ranged from a low of $0.0653 (Jan 18, 2023) to a high of $0.1995 (May 11, 2016), with a median of $0.0926 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 40 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOXETINE HCL 40 MG CAPSULE, is $0.0499 per EA — about 32% below FLUOXETINE HCL 40 MG CAPSULE.
Who manufactures FLUOXETINE HCL 40 MG CAPSULE?
FLUOXETINE HCL 40 MG CAPSULE (NDC 42543072705) is labeled by Vensun Pharmaceuticals, Inc., and CMS classifies it as a generic product.